Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

25 Nov 2014 07:00

RNS Number : 8702X
Byotrol PLC
25 November 2014
 



 

25 November 2014

 

Byotrol plc

BOARD APPOINTMENT

 

Byotrol plc ("Byotrol" or "the company", the leading AIM listed anti-microbial hygiene company, today announces the appointment of Dr Trevor Francis to its board as Chief Technology Officer with immediate effect.

 

Dr Francis has been working as a consultant to the Company in various positions over the last six years, particularly in consumer product development and commercialisation. Prior to joining Byotrol, Dr Francis spent 29 years at Unilever where he became Vice President of the Global R&D Homecare division and Head of the European Fabric Conditioners & Global Fragrance divisions.

 

Dr Francis is also a board trustee of the Liverpool School of Tropical Medicine where he serves on the Audit and Remuneration Committees.

 

Commenting on the appointment, Nicholas Martel, Chairman of Byotrol, said:

 

"We are delighted to welcome Trevor to the Board. His proven experience of delivering innovative products to market will be invaluable as we seek to consolidate on the recent improvements made within the Company."

 

The following information in relation to the appointment of Dr Francis is disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies:

 

Full Name: Dr Thomas Trevor Francis

Age: 64

 

Current Directorships and Partnerships

Directorships and Partnerships held in the last five years

Tecnoform Associates Limited

None

Liverpool School of Tropical Medicine

 

Shareholding in Company

Options held over Company Shares

% Shareholding in Company post option exercise

Trevor Francis

739,846

2,250,000

1.33%

 

Dr Francis does not have a cash bonus scheme for the financial year ending 31 March 2015.

 

The options for Dr Francis have been granted in the Company's Enterprise Management Incentive Scheme.

 

There are no other matters which are required to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

 

Enquiries:

 

Byotrol plc

01925 742 000

David Traynor - Chief Executive

Dawn Williams - Group Marketing Controller

 

 

finnCap Ltd

020 7220 0500

Geoff Nash

Christopher Raggett

 

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology company, operating globally in the Food, Industrial, Healthcare and Consumer sectors, providing low toxicity products with a broad-based and long-lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, mycobacteria and algae.

Powerful, long-lasting and gentle, Byotrol's products can be used stand alone or as an ingredient within existing products, where Byotrol can significantly improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives for everyone.

 

For more information, please go to www.byotrol.co.uk 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGGMCGUPCGRC
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.